Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Known heart failure drug studied for AML

July 28, 1997

Sparta's oral chemotherapeutic agent enters clinical trials

July 25, 1997

Cambridge NeuroScience awarded SBIR grant for cancer research

July 25, 1997

Asta prepares and evaluates targeted cytotoxic anthracycline analogues

July 24, 1997

Ansan announces merger with Discovery Laboratories and licensing agreement with Titan

July 24, 1997

IDEC acquires anticancer agent from Pharmacia & Upjohn

July 23, 1997

Emitefur: phase II results in breast, gastric and pancreatic cancer

July 23, 1997

Update on Sugen's SU-101

July 23, 1997

Pharmacokinetics of S-1 in tumor-bearing animals

July 23, 1997

TZT-1027 exhibits promising preclinical profile

July 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...